← Open Payments lookup

RADHIKA RAO: Open Payments

NPI 1952485708 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,107 in 131 payments from 17 companies in 2025. Trend: 2023 $3,138 · 2024 $2,084 · 2025 $2,107

Food & beverage: $2,107
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.27$451
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$310
ABBVIE INC.12$250
E.R. Squibb & Sons, L.L.C.17$213
Teva Pharmaceuticals USA, Inc.15$212
Neurocrine BioSciences, Inc.11$176
Axsome Therapeutics, Inc.9$144
Tris Pharma Inc5$88
Takeda Pharmaceuticals U.S.A., Inc.4$63
Collegium Pharmaceutical, Inc.3$52

Products named: REXULTI, CAPLYTA, VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, Auvelity, Dyanavel XR.

Industry payments across MO — which companies pay providers there.